Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
Authors
Keywords
Biomarkers, Research reporting guidelines, Scientific publishing, Medicine and health sciences, Bibliometrics, Breast cancer, Prognosis, Research design
Journal
PLoS One
Volume 12, Issue 6, Pages e0178531
Publisher
Public Library of Science (PLoS)
Online
2017-06-15
DOI
10.1371/journal.pone.0178531
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increasing value and reducing waste in biomedical research: who's listening?
- (2016) David Moher et al. LANCET
- Reproducible Research Practices and Transparency across the Biomedical Literature
- (2016) Shareen A. Iqbal et al. PLOS BIOLOGY
- Methodology and reporting quality of reporting guidelines: systematic review
- (2015) Xiaoqin Wang et al. BMC Medical Research Methodology
- Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines
- (2015) Lucy Jankova et al. Proteomics Clinical Applications
- Making research articles fit for purpose: structured reporting of key methods and findings
- (2015) Douglas G Altman Trials
- The Time Has Come to Register Diagnostic and Prognostic Research
- (2014) D. G. Altman CLINICAL CHEMISTRY
- Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use?
- (2014) Francesca Sanguedolce et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- How should medical science change?
- (2014) Sabine Kleinert et al. LANCET
- Reducing waste from incomplete or unusable reports of biomedical research
- (2014) Paul Glasziou et al. LANCET
- Biomedical research: increasing value, reducing waste
- (2014) Malcolm R Macleod et al. LANCET
- STRengthening Analytical Thinking for Observational Studies: the STRATOS initiative
- (2014) Willi Sauerbrei et al. STATISTICS IN MEDICINE
- Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review
- (2014) A. Stevens et al. BMJ-British Medical Journal
- Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols
- (2014) George Peat et al. PLOS MEDICINE
- Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer
- (2013) Luigi Marchionni et al. ANNALS OF INTERNAL MEDICINE
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Biomarkers in pharmacology and drug discovery
- (2013) D.C. Anderson et al. BIOCHEMICAL PHARMACOLOGY
- A practical guide to epidemiological practice and standards in the identification and validation of diagnostic markers using a bladder cancer example
- (2013) T. Behrens et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Lessons from controversy: biomarkers evaluation
- (2013) Mario Plebani CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Impact of STROBE Statement Publication on Quality of Observational Study Reporting: Interrupted Time Series versus Before-After Analysis
- (2013) Sylvie Bastuji-Garin et al. PLoS One
- Prognosis research strategy (PROGRESS) 4: Stratified medicine research
- (2013) A. D. Hingorani et al. BMJ-British Medical Journal
- Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes
- (2013) H. Hemingway et al. BMJ-British Medical Journal
- Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
- (2013) Richard D. Riley et al. PLOS MEDICINE
- Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
- (2013) Ewout W. Steyerberg et al. PLOS MEDICINE
- The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
- (2012) Eleftherios P Diamandis BMC Medicine
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
- (2012) Douglas G Altman et al. BMC Medicine
- Expression of activated type I receptor tyrosine kinases in early breast cancer
- (2012) Melanie Spears et al. BREAST CANCER RESEARCH AND TREATMENT
- A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
- (2012) J Eberhard et al. BRITISH JOURNAL OF CANCER
- Why Your New Cancer Biomarker May Never Work: Recurrent Patterns and Remarkable Diversity in Biomarker Failures
- (2012) S. E. Kern CANCER RESEARCH
- Commercial Immunoassays in Biomarkers Studies: Researchers Beware!
- (2012) N. Rifai et al. CLINICAL CHEMISTRY
- Biomarker Failures
- (2012) J. P. A. Ioannidis CLINICAL CHEMISTRY
- ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
- (2012) Ashish M. Kamat et al. EUROPEAN UROLOGY
- Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells
- (2012) Maciej Bogdan Maniecki et al. INTERNATIONAL JOURNAL OF CANCER
- Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting
- (2012) Lisa M. McShane et al. JOURNAL OF CLINICAL ONCOLOGY
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
- (2012) Lesley A. Inker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
- (2011) A Larsson et al. BRITISH JOURNAL OF CANCER
- Biomarker studies: a call for a comprehensive biomarker study registry
- (2011) Fabrice Andre et al. Nature Reviews Clinical Oncology
- The quality of reporting of primary test accuracy studies in obstetrics and gynaecology: application of the STARD criteria
- (2011) Tara J Selman et al. BMC Womens Health
- Uses and misuses of the STROBE statement: bibliographic study
- (2011) B. R. da Costa et al. BMJ Open
- p53 immunohistochemistry in bladder cancer—a new approach to an old question
- (2010) Peter J. Goebell et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
- (2009) S Mallett et al. BRITISH JOURNAL OF CANCER
- Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis and beyond
- (2009) R D Riley et al. BRITISH JOURNAL OF CANCER
- STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK… and CONSORT: for whom does the guideline toll?
- (2009) Jan P. Vandenbroucke JOURNAL OF CLINICAL EPIDEMIOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started